|
|
|||||||||||
The British Journal of Psychiatry 150: 180-182 (1987)
© 1987 The Royal College of Psychiatrists
SE Watkins, K Callender, DR Thomas, SF Tidmarsh and DM Shaw
Department of Psychological Medicine, University of Wales College of Medicine.
Times in remission from affective illness were prolonged during treatment with lithium carbonate and carbamazepine, but lithium was the more effective. Similar global scores for the two drugs suggested that other factors may determine their acceptability.
This article has been cited by other articles:
![]() |
A. Cipriani, H. Pretty, K. Hawton, and J. R. Geddes Lithium in the Prevention of Suicidal Behavior and All-Cause Mortality in Patients With Mood Disorders: A Systematic Review of Randomized Trials Am J Psychiatry, October 1, 2005; 162(10): 1805 - 1819. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. TONDO, R. J. BALDESSARINI, and G. FLORIS Long-term clinical effectiveness of lithium maintenance treatment in types I and II bipolar disorders The British Journal of Psychiatry, June 1, 2001; 178 (41): s184 - s190. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Dorson Psychiatric Uses of Anticonvulsants Journal of Pharmacy Practice, January 1, 1990; 3(4): 262 - 275. [Abstract] [PDF] |
||||
![]() |
M. Elphick, F. Lyons, and P.J. Cowen Low tolerability of carbamazepine in psychiatric patients may restrict its clinical usefulness J Psychopharmacol, January 1, 1988; 2(1): 1 - 4. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |